← Browse by Condition
Medical Condition
high grade glioma
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 1, Phase 2, EARLY_Phase 1, Phase 1
ClinicalMetric tracks all active clinical trials for high grade glioma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — high grade glioma Clinical Trials
How many clinical trials are currently recruiting for high grade glioma?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for high grade glioma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for high grade glioma?
high grade glioma research spans Phase 1 (5 trials), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a high grade glioma clinical trial?
Eligibility criteria for high grade glioma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 5
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04865315
Recruiting
Enrollment
50 pts
Location
Netherlands
Sponsor
Maastricht Radiation Oncology
NCT04299191 Phase 1, Phase 2
Recruiting
Enrollment
28 pts
Location
United States
Sponsor
Laminar Pharmaceuticals
NCT06829173 EARLY_Phase 1
Recruiting
Enrollment
39 pts
Location
United States
Sponsor
NYU Langone Health
NCT07480941 Phase 1
Recruiting
Enrollment
36 pts
Location
China
Sponsor
Beijing Biotech
NCT07210632 EARLY_Phase 1
Recruiting
Enrollment
38 pts
Location
United States
Sponsor
Eben Rosenthal
NCT05839379
Recruiting
Enrollment
350 pts
Location
United States, Austr...
Sponsor
Nationwide Children's Hospital
NCT06072586 EARLY_Phase 1
Recruiting
Enrollment
82 pts
Location
United States
Sponsor
St. Joseph's Hospital and Medi...
NCT06215495
Recruiting
Enrollment
88 pts
Location
China
Sponsor
Zhujiang Hospital
NCT06831773
Recruiting
Enrollment
23 pts
Location
China
Sponsor
Gansu Wuwei Tumor Hospital
Related Conditions
glioblastoma (3) low grade glioma (1) solid tumor unspecified child (1) malignant glioma (1) recurrent glioblastoma (1) recurrent high grade glioma (1) brain cancer (1) hgg (1) glioma (1) high grade gliomas (1) high grade glioma iii or iv (1) high grade glioma hgg of the brain with braf aberration (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology